Stock listing

Exelixis, Inc.

Selected listing: E2XE34 · BMFBOVESPA · BRL · BR

Exelixis, Inc. (B3:E2XE34), Health Technology. Latest release Aug 31, 2026: Exelixis Announces Update on Patent Litigation Trial Appeal with MSN Laboratories.

E2XE34:BMFBOVESPABRLBRUpdated October 2, 2026
Exelixis, Inc. logo
Ticker
B3:E2XE34
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
B3
Currency
BRL

About Exelixis, Inc.

Exelixis, Inc. is a publicly traded biotechnology company based in the United States, focused on developing and commercializing innovative therapies for cancer treatment. Exelixis aims to improve the lives of patients through its advanced research and development efforts in oncology.

Latest news from Exelixis, Inc.

Exelixis Announces Update on Patent Litigation Trial Appeal with MSN Laboratories

August 31, 2026

Exelixis Announces Second Quarter 2026 Financial Results and Provides Corporate Update

August 5, 2026

Exelixis to Release Second Quarter 2026 Financial Results on Wednesday, August 5, 2026

July 22, 2026

Exelixis Provides Update on the Phase 3 STELLAR-303 Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Patients with Metastatic Colorectal Cancer

June 21, 2026

Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026

May 29, 2026

All Exelixis, Inc. news →

Events

Replays

  • Exelixis, Inc. (EXEL) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 05:00 PM ET

    Watch

  • Exelixis, Inc. (EXEL) Q1 2026 Earnings Call

    Tue, May 05, 2026 · 05:00 PM ET

    Watch

  • Exelixis, Inc. (EXEL) Q4 2025 Earnings Call

    Tue, Feb 10, 2026 · 05:00 PM ET

    Watch

Research Exelixis, Inc.

Exelixis, Inc. company profile

View the public company page for Exelixis, Inc. on 6ix.

Exelixis, Inc. news

Read company news and market updates connected to Exelixis, Inc..

Exelixis, Inc. investor events

Find investor webinars, events, and replay context for Exelixis, Inc..

Alternate listings

EXEL:NASDAQ

US · USD

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.

EX9:GETTEX

DE · EUR

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.

936718:LSX

DE · EUR

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.

EX9:TRADEGATE

DE · EUR

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.

936718:LS

DE · EUR

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.

0IJO:LSE

GB · USD

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.

EX9:FWB

DE · EUR

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.

1EXEL:MIL

IT · EUR

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.

EXEL:BOATS

US · USD

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.

EX9:SWB

DE · EUR

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.

EX9:BX

CH · CHF

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.

EX9:DUS

DE · EUR

Alternate listing for Exelixis, Inc.; the primary context on this page is E2XE34:BMFBOVESPA.